Clinical trial · Observational
An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial
NCT00384735CI-TRIAL-00047553TOSScompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the impact on overall survival of an intensive follow-up protocol (as practiced today at TMH) against a more cost effective follow-up protocol in patients operated for extremity sarcoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- 1A
- description
- Intensive - 3 monthly follow up
- label
- 1B
- description
- Intensive - 6 monthly follow up
- label
- IIA
- description
- Cost Effective - 3 monthly follow up
- label
- IIB
- description
- Cost Effective - 6 monthly follow up
Primary outcomes (1)
- measure
- Overall Survival
- timeFrame
- Minimum 2 years
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients operated for primary or recurrent extremity bone \& soft tissue sarcomas.(both limb salvage and amputations) 2. Non Metastatic at presentation. 3. Patients reliable for follow-up. Exclusion Criteria: 1. Non-extremity sarcomas. 2. Metastatic at presentation 3. Patients unreliable for follow up.
References
Publications (1)
- DERIVEDPuri A, Gulia A, Hawaldar R, Ranganathan P, Badwe RA. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res. 2014 May;472(5):1568-75. doi: 10.1007/s11999-013-3385-9. Epub 2013 Nov 19. PMID 24249538